Table 9.
Condition | Author/year | Study objective | Study design sample size intervention | Patient description/condition | Primary/main outcome(s) | Main results/conclusions | Adverse events |
---|---|---|---|---|---|---|---|
ADHD | Accorsi A, et al. 2014 [48] | To evaluate efficacy of osteopathic manipulative treatment of children with ADHD. | RCT n = 28 OMT |
Children ages 5–15, with primary diagnosis of ADHD | Biancardi-Stroppa Modified Bell Cancellation Test, accuracy and rapidity scores | Osteopathic manipulative treatment was positively associated with changes in the Biancardi-Stroppa Test accuracy and rapidity scores. | There was no mention of adverse events made in this study. |
Autism | Bramati-Castellarin I, et al. 2016 [49] | Investigate the influence of visceral osteopathic technique on the behaviour and GI symptoms of children with autism. | Interrupted Time Series (without control group) n = 49 VOMT |
Autistic children ages 3 1/2–8, with GI symptoms, impaired social interactions and communication | Parental completion of the Modified Autism Research Institute outcomes survey form (9 S.O.S. questionnaires) and secretin assessment used to assess GI signs and symptoms | Significant improvements reported in “social behavior and communication” and “digestive signs” subscale of the questionnaire and in vomiting and poor appetite comparing before and after VOMT. | “There was no mention of adverse events made in this study.” |
Khorshid K, et al. 2006 [50] | Identify the differences in efficacy between upper cervical and full spine adjustment in autistic children | RCT n = 14 CMT |
Children diagnosed with autism | ATEC average scores and parental observations | Clinical improvements observed through parental observations and through a decrease in the ATEC scores in both groups. Upper cervical group had improved ATEC average scores of 32%. Full spine group had improved ATEC scores of 19%. | Clinical deterioration was shown in one of the children of the full spine group, but only marginal in one child of the upper cervical group. | |
Cerebral Palsy | Wyatt K, et al. 2011 [51] | Evaluate the general health and wellbeing effect of cranial osteopathy on cerebral palsy children. | RCT n = 142 Cranial Osteopathy |
Children with CP, ages 5–12 | Gross Motor Function Measure - (GMFMM-66) Quality of life Child Health Questionnaire-(CHQ) PF50 | No statistical change in GMFM-66 or CHQ. PF50 Parents (unblinded) reported better global health. |
No serious adverse events were reported. |
Duncan B, et al. 2004 [52] | Evaluate effectiveness of osteopathic manipulation or acupuncture as a supplemental therapies for children with spastic cerebral palsy. | RCT n = 50 OMT |
Children with spastic CP, ages 20 months - 12 years | Parent reporting of changes observed (open-ended questions) | 96% reported improvements. Most frequent seen in use of arms and legs (61 and 68%) and more restful sleep (39 and 68%) in osteopathic and acupuncture respectively. Additional improvements also noted in mood and bowel functions. | There was no mention of adverse events made in this study. | |
Duncan B, et al. 2008 [53] | Evaluate effectiveness of osteopathic manipulation (cranial field, myofascial release or both) vs. acupuncture in spastic cerebral palsy patients. | RCT n = 55 OMT/Acupuncture |
Children with CP, ages 20 months - 12 years | 11 outcomes used: Primary-GMFCS, GMFM total percent, PEDI mobility, PEDI self-care, WeeFIM mobility, WeeFIM self-care; Secondary- DO rating of spasticity, MAS biceps, MAS hamstring, parent/guardian rating of arched back, parent/guardian rating of startle reflex | Osteopathic manipulation was associated with improvements in 2 of 11 outcomes; GMFM total percent and WeeFIM Mobility. Acupuncture was not associated with improvements in any of the outcomes variables. | There was no mention of adverse events made in this study. | |
Prematurity | Raith W, et al. 2016 [54] | Investigate neurological short term effects of craniosacral therapy on general movements in preterm infants. | RCT n = 30 OMT/CST |
Preterm infants ages 25–33 weeks, free from medical complications in NICU | Primary outcome: General movement assessment tool. Secondary outcomes: General movement optimality score | No difference in the general movement could be observed between the groups. No change in general movement optimality score was noted. | There was no mention of adverse events made in this study. |
Cerretelli F, et al. 2015 [55] | Investigate whether osteopathic manipulation reduces the length of hospital stay, costs, and weight gain for preterms. | RCT n = 695 OMT/CST |
Preterm infants ages 29–37 weeks, without congenital complications in NICU | 1. Reducing length of hospital stay 2. Weight gain and hospital savings |
Osteopathic treatment reduced days hospital (3.9 days) and reduced costs by 1250.65€ per newborn per length of stay. No change in weight gain was noted. | There were no complications associated to the intervention. | |
Pizzolorusso G, et al. 2014 [56] | Investigate whether osteopathic manipulation reduces length of hospital stay, what effect the timing of introduction of osteopathic treatment may have on the outcome and hospital costs in preterm infants. | RCT n = 110 OMT/CST |
Preterm infants ages 32–37 weeks, free from medical complications in NICU | 1. Reducing length of hospital stay and impact on length of stay of timing of introduction of osteopathic manipulation 2. Reducing hospital cost |
Sooner osteopathic manipulation introduced, shorter length of stay. There is a positive association of osteopathic manipulation with overall reduction in cost of care. | There were no complications associated to the intervention. | |
Cerretelli F, et al. 2013 [57] | Determine effectiveness of osteopathic manipulative therapy in reducing the length of hospital stay, hospital costs and weight gain in preterm infants. | RCT n = 110 OMT/CST |
Preterm infants ages >28 and <38 weeks, free from medical complications in NICU | 1. Decreased length of hospital stay 2. Improved weight gain and reduced NICU costs |
Osteopathic manipulation reduced length of stay and hospital costs but not effect weight gain. | No serious adverse events were reported. |